|
Market Closed -
TEL AVIV STOCK EXCHANGE
18:24:02 10/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 1,138.00 ILa | +5.76% |
|
+4.88% | +4.02% |
| Market Cap | 130M 0 42.68M 36.71M 34.63M 31.55M 58.98M 4.08B 59.52M 412M 159M 2.07B 160M 157M 6.57B | P/E 2024 |
24.5x | P/E 2025 | -6.91x |
|---|---|---|---|---|---|
| Enterprise Value | 258M 0 84.75M 72.88M 68.77M 62.65M 117M 8.1B 118M 819M 315M 4.11B 318M 311M 13.05B | EV / Sales 2024 |
0.87x | EV / Sales 2025 | 0.84x |
| Free-Float |
17.21% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +5.76% | ||
| 1 week | +4.88% | ||
| Current month | +7.46% | ||
| 1 month | +6.95% | ||
| 3 months | +8.38% | ||
| 6 months | -0.44% | ||
| Current year | +4.02% |
| 1 week | 1,060 |  | 1,139 |
| 1 month | 1,026 | | 1,139 |
| Current year | 1,006 | | 1,348 |
| 1 year | 1,006 | | 1,348 |
| 3 years | 1,006 | | 1,788 |
| 5 years | 1,006 | | 2,610 |
| 10 years | 1,006 | | 4,076 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 82 | 24/08/1993 | |
Yuval Bernshtein
DFI | Director of Finance/CFO | 46 | 01/11/2018 |
| President | 80 | 28/06/2010 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 82 | 25/06/2010 | |
| Director/Board Member | 80 | - | |
Avraham Bigger
CHM | Chairman | 80 | 15/04/2015 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +5.76% | +4.88% | -1.90% | -23.98% | 42.68M | |
| -1.21% | -4.40% | +24.72% | +109.34% | 103B | |
| -1.66% | -5.06% | +58.09% | +165.85% | 54.89B | |
| -0.38% | -2.59% | -12.33% | +250.67% | 21.78B | |
| -1.03% | -0.79% | -10.14% | -7.64% | 8.09B | |
| -1.33% | -3.06% | -37.05% | -28.50% | 6.96B | |
| -0.02% | +0.09% | +2.89% | +30.96% | 6.79B | |
| -0.90% | -2.10% | -19.20% | -29.86% | 6.17B | |
| +1.15% | +1.09% | -3.51% | +20.92% | 5.08B | |
| -10.00% | +1.12% | +354.83% | +495.04% | 5.12B | |
| Average | -0.96% | +0.53% | +35.64% | +98.28% | 21.76B | |
| Weighted average by Cap. | -1.34% | -2.67% | +31.34% | +129.58% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 322M 0 106M 90.91M 85.78M 78.14M 146M 10.11B 147M 1.02B 393M 5.13B 397M 388M 16.28B | 301M 0 98.9M 85.06M 80.25M 73.11M 137M 9.46B 138M 956M 368M 4.8B 371M 363M 15.23B |
| Net income | 6.21M 0 2.04M 1.75M 1.65M 1.51M 2.82M 195M 2.84M 19.71M 7.58M 98.89M 7.66M 7.49M 314M | -18.07M -0 -5.94M -5.11M -4.82M -4.39M -8.21M -568M -8.28M -57.39M -22.09M -288M -22.3M -21.81M -915M |
| Net Debt | 127M 0 41.76M 35.91M 33.89M 30.87M 57.71M 3.99B 58.23M 404M 155M 2.03B 157M 153M 6.43B | 128M 0 42.06M 36.17M 34.13M 31.09M 58.13M 4.02B 58.65M 406M 156M 2.04B 158M 155M 6.48B |
Employees
390
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/09/26 | ILA 1,138.00 | +5.76% | 1,001 |
| 09/09/26 | ILA 1,076.00 | +0.65% | 394 |
| 08/09/26 | ILA 1,069.00 | -1.02% | 4,242 |
| 07/09/26 | ILA 1,080.00 | 0.00% | 4,307 |
| 04/09/26 | ILA 1,080.00 | -0.46% | 415 |
- Stock Market
- Stocks
- REKA Stock
Select your edition
All financial news and data tailored to specific country editions
